Patient-related healthcare costs for diarrhoea, Guillain Barré syndrome and invasive non-typhoidal salmonellosis in Gondar, Ethiopia, 2020

Table 13 Estimated national cost-of-illness due to foodborne diseases caused by Campylobacter spp. (Camp), enterotoxigenic Escherichia coli (ETEC) and non-typhoidal Salmonella enterica (Salm) in Ethiopia in 2017

Pathogen	Health state	Incidence^a	Direct medical costs		(In)direct non-medical costs		Total costs per health state (mln USD)	Total costs per pathogen (mln USD)^d
Pathogen	Health state	Incidence^a	Costs / patient (USD) ^b	Total (mln ^c USD)	Costs / patient (USD) ^b	Total (mln USD)	Total costs per health state (mln USD)	Total costs per pathogen (mln USD)^d
Camp	diarrhoea	2.8 mln	8.96	25.1	58	162.4	187.5	187.8
Camp	GBS	1,200	267.70	0.3	26.17	0.0	0.4
ETEC	diarrhoea	1.1 mln	8.96	9.6	58	62.1	71.6	71.6
Salm	diarrhoea	1.1 mln	8.96	9.9	58	63.8	73.7	83.9
Salm	iNTS	140,000	47.79	6.7	25.37	3.6	10.2
All				51.5		291.8	343.4	343.4

^aDiarrhoea incidence from Havelaar, et al. [18]. GBS and iNTS incidence based on age-weighted probabilities of developing GBS and iNTS as sequelae to diarrhoea by Campylobacter spp. and non-typhoidal Salmonella enterica, respectively, extracted from the FERG database
^bDiarrhoea from Table 3, GBS from Table 10 and iNTS from Table 12. Note that for GBS and iNTS, these include only ambulance cost whereas for diarrhoea these include transport costs and lost income
^cmillion
^dDifferences with sum of costs per health state due to rounding

ISSN: 1471-2458